Did you miss these Quarterly Updates - AZI, SRK, LVT, BRN, IHL, IBX,...

Summary Domestic reporting season has begun with companies declaring their June quarter results/quarterly activity reports. The drilling results p...

ASX Earnings Season Trends: GUD CCP TPW

Summary Investors had been waiting for the June quarter results edgily as the effects of the lockdown, and social distancing get subsumed in the re...

SUDA Reaches Major Milestone with Grant of TGA Approval for ZolpiMis...

SUDA Pharmaceuticals Limited (ASX:SUD) soared above 150 per cent to $0.068 on ASX on 29 July 2020, following the announcement regarding grant of Thera...

Platina Resources’ Working Capital Position Strengthened with Palisa...

Western Australia-headquartered Platina Resources Limited (ASX: PGM) has received commitments from a non-brokered private placement of 22.36...

Lens on Popular Stocks: WBC, CBA, RIO, BHP, ILU, IPD, VHT, SRG

Summary The second wave of COVID-19 cases has again caused uncertainty in the market where stocks from various sectors ended in the red zone on 29...

Scan Through Mount Burgess’ Remarkable June Quarter Performance

Summary Mount Burgess has developed resources in Kihabe and Nxuu Deposits on PL43/2016 in Western Ngamiland Botswana. Work across quarter ended 30...

Flick Through Imugene’s June 2020 Quarter Milestones

Clinical stage immuno-oncology company, Imugene Limited (ASX:IMU) marked an uptick of ~22.6 per cent to $0.065 on ASX following the release of its sol...

Latest with Consumer Staples Stock- MCP

Summary Investors have repeatedly shown that they prefer small caps when uncertainty fades and risk appetites return. McPherson’s, a small-c...

Calima’s June 2020 Quarter Report Card Out! Reflects Two Key Achieve...

Summary Calima attained two significant milestones during the June quarter, including the finalisation of Tommy Lakes’ acquisition and comple...

WHK secures 5-year Cyber Risk Radar contract from the US Government;...

Summary Owing to a surge in the cybercrimes and frauds, cybersecurity players such as WhiteHawk have strengthened and expanded at an accelerated pa...

Scan Through Cobalt Blue’s June 2020 Quarterly Report With Noteworth...

Summary Cobalt Blue achieved significant testwork outcome, with samples from BHCP delivering 37% Co and 7% Ni in the MHP intermediate product. Pil...

Wisr Stock Price Under Discussion: Future of Financial Products

Summary Wisr, the only ASX-listed neo-lender & a fintech pioneer in the fast-rising Australian customer finance market, reported a 50% growth i...

Wingara AG Defies COVID-19 headwinds; Delivers 31% Growth in Custome...

Summary Wingara Ag Limited witnessed continuous improvement in overall revenue profile amid the COVID-19 pandemic. Cash receipts marked an uptick...

A new Shot of Bonanza Gold Grades at Starlight Adds Another Feather...

Australian gold explorer, Musgrave Minerals Limited (ASX: MGV) reports another set of high-grade gold results at  the new Starlight gold discover...

REFFIND Envisions Substantial Value Addition for Investors through S...

Summary REFFIND has proposed a strategy to monetise its investment in Loyyal and maximise shareholder value. As a result of the impacts being felt...

Walk Through GTI Resources’ Splendid Journey in June 2020 Quarter

Australian mineral exploration firm focused on vanadium and uranium, GTI Resources Limited (ASX:GTR) has recently released quarterly results for the J...

King River Resources’ Quarterly Report Card Shining with Imprints of...

Manoeuvring forward smoothly by virtue of its sheer exploration efforts, King River Resources Limited (ASX: KRR) appears to have carved significant de...

MGC Pharmaceuticals under the Spotlight: Small-cap cannabis player m...

Summary EU biopharma player MGC Pharmaceuticals announced favourable safety and tolerability results for COVID-19 treatment candidate, ArtemiC in a...

Popular Stocks to Look At – NAN, NCM, NEA, NCK 

Summary Amid the ongoing COVID-19 pandemic, there are several companies that continue to perform well. Newcrest Mining registered strong Q4 perfor...

Noxopharm: Latest Data Validates Potential of Veyonda®’s Idronoxil t...

New important pre-clinical data from two independent laboratories has validated the potential of Noxopharm Limited’s (ASX:NOX) idronoxil (active...